A/RES/76/175 GA
Ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID-19) pandemic : resolution / adopted by the General Assembly
76
Session
179
Yes
0
No
7
Abstentions
| Draft symbol | A/C.3/76/L.55/Rev.1 |
|---|---|
| Adopted symbol | A/RES/76/175 |
| Category | SOCIAL CONDITIONS AND EQUITY |
| P5 Positions |
|
| UN Document | A/RES/76/175 ↗ |
Vote Recorded Vote — A/76/PV.53
-
Afghanistan
-
Albania
-
Algeria
-
Andorra
-
Angola
-
Antigua and Barbuda
-
Argentina
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Barbados
-
Belarus
-
Belgium
-
Belize
-
Benin
-
Bhutan
-
Plurinational State of Bolivia
-
Bosnia and Herzegovina
-
Botswana
-
Brazil
-
Brunei Darussalam
-
Bulgaria
-
Burkina Faso
-
Burundi
-
Cabo Verde
-
Cambodia
-
Cameroon
-
Canada
-
Central African Republic
-
Chad
-
Chile
-
China
-
Colombia
-
Comoros
-
Côte d'Ivoire
-
Costa Rica
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
Democratic People's Republic of Korea
-
Denmark
-
Djibouti
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Equatorial Guinea
-
Eritrea
-
Estonia
-
Eswatini
-
Ethiopia
-
Fiji
-
Finland
-
France
-
Gabon
-
Gambia
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Grenada
-
Guatemala
-
Guinea
-
Guinea-Bissau
-
Guyana
-
Haiti
-
Honduras
-
Hungary
-
Iceland
-
India
-
Indonesia
-
Islamic Republic of Iran
-
Iraq
-
Ireland
-
Italy
-
Jamaica
-
Jordan
-
Kazakhstan
-
Kenya
-
Kiribati
-
Kuwait
-
Kyrgyzstan
-
Lao People's Democratic Republic
-
Latvia
-
Lebanon
-
Lesotho
-
Liberia
-
Libya
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malawi
-
Malaysia
-
Maldives
-
Mali
-
Malta
-
Marshall Islands
-
Mauritania
-
Mauritius
-
Mexico
-
Micronesia (Federated States of)
-
Monaco
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nicaragua
-
Niger
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palau
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Qatar
-
Moldova
-
Romania
-
Russian Federation
-
Rwanda
-
Saint Kitts and Nevis
-
Saint Lucia
-
Saint Vincent and the Grenadines
-
Samoa
-
San Marino
-
Saudi Arabia
-
Senegal
-
Serbia
-
Seychelles
-
Sierra Leone
-
Singapore
-
Slovakia
-
Slovenia
-
Solomon Islands
-
Somalia
-
South Africa
-
South Sudan
-
Spain
-
Sri Lanka
-
Sudan
-
Suriname
-
Sweden
-
Switzerland
-
Syrian Arab Republic
-
Tajikistan
-
Thailand
-
Timor-Leste
-
Togo
-
Tonga
-
Trinidad and Tobago
-
Tunisia
-
Türkiye
-
Turkmenistan
-
Uganda
-
United Arab Emirates
-
United Republic of Tanzania
-
Uruguay
-
Uzbekistan
-
Vanuatu
-
Bolivarian Republic of Venezuela
-
Viet Nam
-
Yemen
-
Zambia
-
Zimbabwe
Full text of resolution
United Nations
A/RES/76/175
General Assembly
Distr.: General
10 January 2022
21-19211 (E) 140122
*2119211*
Seventy-sixth session
Agenda item 74 (b)
Promotion and protection of human rights: human
rights questions, including alternative approaches for
improving the effective enjoyment of human rights and
fundamental freedoms
Resolution adopted by the General Assembly
on 16 December 2021
[on the report of the Third Committee (A/76/462/Add.2, para. 114)]
76/175. Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
The General Assembly,
Guided by the purposes and principles of the Charter of the United Nations,
Stressing that States bear the primary responsibility to respect, protect and fulfil
human rights and fundamental freedoms,
Recalling that one of the purposes of the United Nations is to achieve
international cooperation in solving international problems of an economic, social,
cultural or humanitarian character and in promoting and encouraging respect for
human rights and fundamental freedoms for all, without distinction of any kind,
Recalling also the Universal Declaration of Human Rights,1 the International
Covenant on Civil and Political Rights,2 the International Covenant on Economic,
Social and Cultural Rights, 3 the Convention on the Elimination of All Forms of
Discrimination against Women, 4 the Convention on the Rights of the Child, 5 the
__________________
1 Resolution 217 A (III).
2 See resolution 2200 A (XXI), annex.
3 Ibid.
4 United Nations, Treaty Series, vol. 1249, No. 20378.
5 Ibid., vol. 1577, No. 27531.
A/RES/76/175
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
21-19211
2/8
Convention on the Rights of Persons with Disabilities 6 and the International
Convention on the Elimination of All Forms of Racial Discrimination, 7
Recalling further other relevant international human rights instruments,
including the Declaration on the Right to Development,8 and the Vienna Declaration
and Programme of Action, 9 in which it is established that all human rights are
universal, indivisible and interdependent and interrelated,
Reaffirming its resolution 70/1 of 25 September 2015, entitled “Transforming
our world: the 2030 Agenda for Sustainable Development”, and the Sustainable
Development Goals enshrined therein, in particular the commitment made by all
States to ensure healthy lives and promote well-being for all at all ages, to achieve
gender equality and to reduce inequalities within and among countries,
Reaffirming also its resolution 69/313 of 27 July 2015 on the Addis Ababa
Action Agenda of the Third International Conference on Financing for Development,
which is an integral part of the 2030 Agenda for Sustainable Development,
Recalling its resolutions 74/270 of 2 April 2020, 74/274 of 20 April 2020 and
74/306 and 74/307 of 11 September 2020, and Human Rights Council resolutions
41/10 of 11 July 2019,10 44/2 of 16 July 202011 and 46/14 of 23 March 2021,12
Noting World Health Assembly resolutions 73.1 of 19 May 2020 and 74.7 of
31 May 2021, as well as World Health Assembly decision 74(16) of 31 May 2021,
Recalling Security Council resolution 2532 (2020) of 1 July 2020,
Recognizing the appeals of the Secretary-General concerning the response to the
impact of the coronavirus disease (COVID-19) pandemic, with a particular emphasis
on countries in need,
Recalling the outcome of the high-level meeting on universal health coverage,
reaffirming its political declaration, entitled “Universal health coverage: moving
together to build a healthier world”,13 and recognizing further that universal health
coverage implies that all people have access, without discrimination, to nationally
determined sets of needed promotive, preventive, curative, palliative and
rehabilitative essential health-care services and essential, safe, affordable, effective
and quality medicines, vaccines, therapeutics and diagnostics, while ensuring that the
use of these services does not expose users to financial hardship, with special
emphasis on the poor and other people in vulnerable situations,
Expressing solidarity with all people and countries affected by the pandemic,
and condolences and sympathy to the families of the victims of COVID-19 and those
whose lives and livelihoods have been affected by the pandemic,
Recognizing that the availability of vaccines, medicines, health technologies and
health therapies is an essential dimension of the right of everyone to the enjoyment
of the highest attainable standard of physical and mental health,
__________________
6 Ibid., vol. 2515, No. 44910.
7 Ibid., vol. 660, No. 9464.
8 Resolution 41/128, annex.
9 A/CONF.157/24 (Part I), chap. III.
10 See Official Records of the General Assembly, Seventy-fourth Session, Supplement No. 53
(A/74/53), chap. V, sect. A.
11 Ibid., Seventy-fifth Session, Supplement No. 53 (A/75/53), chap. V, sect. A.
12 Ibid., Seventy-sixth Session, Supplement No. 53 (A/76/53), chap. V, sect. A.
13 Resolution 74/2.
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
A/RES/76/175
3/8
21-19211
Noting that, since the beginning of the vaccine roll-out, the majority of all
vaccines administered have been concentrated in high-income countries, while low-
income countries still lag behind in gaining access to COVID-19 vaccines,
Expressing its serious concern over the disparity between developing countries
and developed countries in terms of the distribution of COVID-19 vaccines, which
prevents the entire international community from achieving the complete elimination
of COVID-19 as soon as possible and also further hampers progress in the realization
of the 2030 Agenda for Sustainable Development,
Recognizing the need to tackle health inequities and inequalities within and
among countries through political commitment, international cooperation and
policies, including those that address the social, economic and environmental
determinants of health,
Welcoming the global initiatives promoting global solidarity in response to the
pandemic, including the efforts of countries that have supplied COVID-19 vaccines,
and recalling the thirty-first special session of the General Assembly, in response to
the COVID-19 pandemic, held on 3 and 4 December 2020, and the high-level meeting
of the Assembly on universal health coverage, held on 23 September 2019,
Recognizing that the encouragement and development of international
partnerships and cooperation in the scientific and cultural fields contribute to the
realization of the right of everyone to the enjoyment of the highest attainable standard
of physical and mental health, bearing in mind that everyone has the right to enjoy
the benefits of scientific progress and its applications,
Recognizing also the importance of international cooperation and effective
multilateralism in ensuring that all States, in particular developing States, including
the least developed countries, have affordable, timely, equitable and universal access
to COVID-19 vaccines in order to minimize negative effects in all affected States and
to avoid the resurgence of the pandemic,
Recognizing further the important role that civil society, including
non-governmental organizations and women’s and community-based organizations,
youth-led organizations and all other stakeholders such as volunteers and national
human rights institutions where they exist, as well as the academic and scientific
community and the private sector play in the response to the COVID-19 pandemic
and its consequences,
Reaffirming the importance of improving the transparency of markets for
medicines, vaccines and other health products across the whole value chain,
Taking note of the guidance issued by the treaty bodies and the special
procedures of the Human Rights Council on States’ human rights obligations in the
context of the COVID-19 pandemic, in particular the statement issued on
15 December 2020 by the Committee on Economic, Social and Cultural Rights on
universal and equitable access to COVID-19 vaccines14 and the joint statement of
several special procedure mandate holders entitled “Universal access to vaccines is
essential for the prevention and containment of COVID-19 around the world”,
Taking note with appreciation of the guidance note issued on 13 May 2020 by
the Office of the United Nations High Commissioner for Human Rights, on human
rights-compliant responses to the COVID-19 pandemic, and the guidance note issued
by the Office on 17 December 2020, on human rights and access to COVID-19
vaccines,
__________________
14 E/C.12/2020/2.
A/RES/76/175
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
21-19211
4/8
Taking note of the report of the United Nations High Commissioner for Human
Rights on the impact of the COVID-19 pandemic on the enjoyment of human rights
around the world, including good practices and areas of concern, 15
Reaffirming the right of everyone to the enjoyment of the highest attainable
standard of physical and mental health, which requires that States take the steps
necessary to prevent, treat and control epidemic, endemic, occupational and other
diseases and to create the conditions that would assure medical services and medical
attention for all in the event of sickness,
Deeply concerned about the negative impact of the COVID-19 pandemic on the
enjoyment of human rights around the world, and emphasizing the importance of
human rights in shaping the response to the pandemic, in terms of both the public
health emergency and the broader impact on people’s lives and livelihoods,
Underscoring that equitable access to health products is a matter of global
priority and that the availability, accessibility, acceptability and affordability of health
products of assured quality are fundamental to tackling the pandemic, and expressing
its concern about the fact that the unequal distribution of vaccines delays the end of
the pandemic,
Reaffirming the fundamental role of the United Nations system in coordinating
the global response to control and contain the spread of COVID-19 and in providing
support to States, and in this regard acknowledging the crucial leading role played by
the World Health Organization, in line with its constitutional mandate,
Emphasizing the central role of the State in responding to pandemics and other
health emergencies, and the socioeconomic consequences thereof, and in advancing
sustainable development and the realization of human rights,
Recognizing the primary responsibility of States to adopt and implement
responses to the COVID-19 pandemic that are specific to their national context, and
that emergency measures taken by Governments in response to the COVID-19
pandemic must be necessary, proportionate to the evaluated risk, applied in a
non-discriminatory way, have a specific focus and duration and be in accordance with
States’ obligations under applicable international human rights law,
Recognizing also that the COVID-19 pandemic has a disproportionately heavy
impact on women, older persons, youth and children, as well as the poor, people in
vulnerable situations and migrants,
Deeply concerned about the disproportionate and negative impact of the
COVID-19 pandemic on the enjoyment of human rights by women and girls and on
gender equality worldwide, including due to the increased incidence of domestic
violence and interrupted access to sexual and reproductive health, and underscoring
the need to ensure a gender-sensitive and people-centred recovery with full respect
for human rights, mindful in particular of the need to ensure the full enjoyment by
women and girls of their human rights,
Recognizing that persons with disabilities face a greater risk of COVID-19
infection and have higher mortality rates, and face aggravated barriers to accessing
COVID-19 information, as well as to timely and quality health-care services,
Deeply concerned that the COVID-19 pandemic perpetuates and exacerbates
existing inequalities and that those most at risk are people in vulnerable situations,
including older persons, migrants, refugees, internally displaced persons, persons
with disabilities, people living with HIV/AIDS, persons belonging to national or
ethnic, religious and linguistic minorities, local communities, indigenous peoples,
__________________
15 A/HRC/46/19.
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
A/RES/76/175
5/8
21-19211
persons deprived of their liberty, homeless persons and persons living in poverty, and
recognizing the need to ensure non-discrimination and equality while stressing the
importance of age-responsive and gender- and disability-sensitive measures in this
regard,
Noting with concern the uneven access to quality, safe, efficacious and
affordable COVID-19 vaccines and the difficulties that a large number of countries
face in gaining access to and supplying them to their populations, stressing the
important role of the Access to COVID-19 Tools (ACT) Accelerator initiative and of
other relevant initiatives that are aimed at accelerating the development and
production of and equitable access to COVID-19 diagnostics, therapeutics and
vaccines for all countries and at strengthening health systems, and recognizing in
particular the vaccines pillar of the COVID-19 Vaccine Global Access (COVAX)
Facility, which is aimed at ensuring an equitable global distribution of vaccines to all
States,
Recognizing that the COVID-19 pandemic requires a global response that is
people-centred,
gender-responsive,
with
full
respect
for
human
rights,
multidimensional, coordinated, inclusive and innovative, based on unity, solidarity
and multilateral cooperation, to ensure that all States, in particular developing States,
including the least developed countries, have unhindered, timely, fair and equitable
access to safe diagnostics, therapeutics, medicines, vaccines and essential health
technologies and their components, as well as equipment, bearing in mind that
immunization against COVID-19 is a global public good for health in preventing,
containing and stopping transmission, and in bringing the pandemic to an end,
Noting the oral update provided by the United Nations High Commissioner for
Human Rights to the Human Rights Council, at its forty-eighth session, on the human
rights implications of the lack of affordable, timely, equitable and universal access to
and distribution of COVID-19 vaccines and the deepening inequalities between
States, including the related vulnerabilities and challenges and the impact on the right
of everyone to the enjoyment of the highest attainable standard of physical and mental
health,
Noting also the Strategy to Achieve Global COVID-19 Vaccination by mid-2022
developed by the secretariat of the World Health Organization, which outlines the
urgent actions required by the global community to vaccinate 40 per cent of the
population of all countries against COVID-19 by the end of 2021 and 70 per cent by
mid-2022, anchored in the principles of equity, quality, integration and inclusivity,
1.
Emphasizes the urgent need to ensure the right of everyone to the
enjoyment of the highest attainable standard of physical and mental health and to
facilitate the development of robust health systems and universal health coverage,
encompassing universal, timely and equitable access to all essential health
technologies, diagnostics, therapeutics, medicines and vaccines in response to the
COVID-19 pandemic and other health emergencies, in order to ensure full access to
immunization for all, in particular people in vulnerable situations, as a matter of
global priority for all States;
2.
Calls upon States and other relevant stakeholders to take appropriate
measures to guarantee fair, transparent, equitable, efficient, universal and timely
access to and distribution of safe, quality, efficacious, effective, accessible and
affordable COVID-19 vaccines and to enable international cooperation;
3.
Calls for the accelerated provision of 550 million more doses of
COVID-19 vaccines to the COVID-19 Vaccine Global Access (COVAX) Facility by
the end of December 2021 in order to get on track to ensure global access to vaccines
to face the pandemic;
A/RES/76/175
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
21-19211
6/8
4.
Also calls for intensified international cooperation and solidarity to
contain, mitigate and overcome the pandemic and its consequences, through
responses that are people-centred, gender-responsive, multidimensional, coordinated,
inclusive, innovative, swift and decisive at all levels, with full respect for human
rights, including by supporting the exchange of information, scientific knowledge and
best practices, and enhancing capacity in particular to assist people in vulnerable
situations, and the poorest and most vulnerable countries, to build a more equitable,
inclusive, sustainable and resilient future and to realize the 2030 Agenda for
Sustainable Development;16
5.
Encourages States to work in partnership with all relevant stakeholders to
increase research and development funding for vaccines, medicines, therapeutics and
diagnostics, leverage digital technologies and strengthen the scientific international
cooperation necessary to combat COVID-19 and to bolster coordination, including
with the private sector, towards the further development, manufacturing and
distribution of diagnostics, antiviral medicines, therapeutics, personal protective
equipment and vaccines while adhering to the objectives of quality, efficacy, safety,
equity, accessibility and affordability;
6.
Recognizes the importance of tools to achieve extensive immunization
against COVID-19 as a global public good for health in preventing, containing and
stopping transmission, and to bring the pandemic to an end, by ensuring the
availability of safe, quality, efficacious, effective, accessible and affordable vaccines;
7.
Calls upon States and other relevant stakeholders to remove unjustified
obstacles restricting the export of COVID-19 vaccines, resulting in an unequal
distribution in access thereto between developed and developing countries, and to
promote the equitable global distribution of and universal access to vaccines, in order
to further the principles of international cooperation and solidarity, to end the current
pandemic and to promote the realization of the right of everyone to the enjoyment of
the highest attainable standard of physical and mental health;
8.
Urges States to facilitate the trade in, acquisition of, access to and
distribution of COVID-19 vaccines as a crucial element of their responses to the
pandemic, to ensure the right of everyone to the enjoyment of the highest attainable
standard of physical and mental health and to support the administration of vaccines
to address the pandemic, in line with the Sustainable Development Goals and in
accordance with the relevant international legal frameworks, including international
human rights obligations, taking into account the principles of non-discrimination and
transparency;
9.
Reiterates the call for States to continue to collaborate, as appropriate, on
models and approaches that support the delinking of the cost of new research and
development from the prices of medicines, vaccines and diagnostics for diseases, to
ensure their sustained accessibility, affordability and availability and to support
access to treatment for all those in need;
10. Calls upon States and all relevant stakeholders to promote research and
capacity-building initiatives and to enhance cooperation on and access to science,
innovation, technologies, technical assistance, transfer of technology and knowledge-
sharing, to ensure universal, equitable and affordable access for all persons to
COVID-19 vaccines, including through improved coordination among mechanisms,
especially with developing countries, in a collaborative, coordinated and transparent
manner and on mutually agreed terms, in response to the COVID-19 pandemic and
towards advancing the realization of the Sustainable Development Goals;
__________________
16 Resolution 70/1.
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
A/RES/76/175
7/8
21-19211
11.
Urges States to leverage digital technologies for the response to
COVID-19, including in support of efficient, transparent and robust immunization,
addressing the socioeconomic impact of COVID-19, paying particular attention to
digital inclusion, patient empowerment and the right to privacy and protection of
personal data;
12. Reaffirms the right of States to use, to the fullest extent, the provisions of
the World Trade Organization Agreement on Trade-Related Aspects of Intellectual
Property Rights (TRIPS Agreement) and the flexibilities therein, as reaffirmed in the
Doha Declaration on the TRIPS Agreement and Public Health, which recognizes that
intellectual property protection is important for the development of new medicines
and also recognizes the concerns about its effects on prices and recognizes further
that the Agreement should be interpreted and implemented in a manner supportive of
the right of States to protect public health, in particular to promote access to
medicines for all, to facilitate access for all to COVID-19 vaccines and to bolster
coordination, including with the private sector, towards the rapid development,
manufacturing and distribution of vaccines, while adhering to the objectives of
transparency, efficacy, safety, equity, accessibility and affordability;
13. Calls upon States, other partners and donors to urgently support funding
and close the funding gap for the Access to COVID-19 Tools (ACT) Accelerator and
its mechanisms, such as the COVAX Facility, to support the equitable distribution of
diagnostics, therapeutics and vaccines and to further explore innovative financing
mechanisms aimed at ensuring affordable, timely, equitable and universal access to,
and the fair distribution of, COVID-19 vaccines for all and the continuity and
strengthening of essential health-care services;
14. Welcomes steps taken to provide a suspension of debt service payments for
the poorest countries, and by international financial institutions to provide liquidity
and other support measures to ease the debt burden of developing countries, and
encourages all relevant actors, including private and commercial creditors, to address
risks of debt vulnerabilities, through existing channels, in developing countries due
to the pandemic;
15. Notes the most recent decision of the International Monetary Fund to
allocate special drawing rights to boost global liquidity and enhance the resilience of
the international monetary system, as part of ongoing efforts to support a
comprehensive response to and recovery from the COVID-19 pandemic, and, in this
regard, highlights the call for countries to consider voluntarily channelling unutilized
special drawing rights, in accordance with national laws and regulations, to the
countries which are most in need, including the middle-income countries, to better
support sustainable development and a more inclusive recovery, and stresses the
importance of ensuring equal access to such resources, to guarantee timely and
universal access to COVID-19 vaccines;
16. Calls upon the international community to continue to assist developing
countries in promoting the full realization of the right of everyone to the enjoyment
of the highest attainable standard of physical and mental health and the right of
everyone to enjoy the benefits of scientific progress and its applications, including
through access to medicines that are affordable, safe, efficacious and of quality and
through financial and technical support for and training of personnel, while
recognizing that the primary responsibility for promoting and protecting all human
rights rests with States;
17. Requests all States, international organizations and relevant stakeholders
to support transparency in all matters relating to the production, distribution and fair
pricing of vaccines, in accordance with national and regional legal frameworks and
contexts, and urges States to take immediate steps to prevent speculation and undue
A/RES/76/175
Ensuring equitable, affordable, timely and universal access for all
countries to vaccines in response to the coronavirus disease
(COVID-19) pandemic
21-19211
8/8
export controls and stockpiling that may hinder affordable, timely, equitable and
universal access for all countries to COVID-19 vaccines;
18. Recognizes the immense logistical challenges posed by the lack of
infrastructure for the distribution of vaccines in developing countries, including the
least developed countries, and calls for greater assistance and building the capacities
of developing countries, including through effective training programmes in vaccine
delivery in this regard;
19. Strongly urges all States to refrain from taking any economic, financial or
trade measures that may adversely affect equitable, affordable, fair, timely and
universal access to COVID-19 vaccines, in particular in developing countries;
20. Urges Member States to promote an enhanced response to future
pandemics based on experience gained and the lessons learned from the COVID-19
pandemic and other public health emergencies of international concern, including by
building, strengthening and maintaining the capacities required under the
International Health Regulations (2005)17 and by supporting the ongoing efforts in
the World Health Assembly to consider the benefits of developing a World Health
Organization convention, agreement or other international instrument on pandemic
preparedness and response, while taking into account all the obstacles that impeded
the effective response to, and treatment of, the disease as well as the need for all
countries to have unhindered access to vaccines and essential health products;
21. Requests the Secretary-General to report to the General Assembly at its
seventy-seventh session on the implementation of the present resolution.
53rd plenary meeting
16 December 2021
__________________
17 World Health Organization, document WHA58/2005/REC/1, resolution 58.3, annex.
▶ Cite this page
UN Project. “A/RES/76/175.” UN Project, https://un-project.org/votes/resolution/A-RES-76-175/. Accessed .